FDA Investigator: Jasmine Y. Wang
- Jasmine Y. Wang first started conducting FDA inspections in 2023, with the last inspection in 2024. Over that time, Jasmine Y. Wang has conducted 22 inspections at 22 companies across 22 sites.
Get Jasmine Wang's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Lisa S. Wang, M.D, Whittier | October 2023
Available Now - $199
Jasmine Y. Wang
Human Drugs Form 483
FDA 483 Daniel H. Ahn D.O, Phoenix | September 2023
Available Now - $199
Jasmine Y. Wang
Human Drugs Form 483
FDA 483 Dignity Health St. Joseph's IRB, Phoenix | 2024
Out-of-stock
Jasmine Y. Wang
Biologics Form 483
FDA 483 Paul La Porte, M.D., Cerritos | 2024
Out-of-stock
Jasmine Y. Wang
Human Drugs Form 483
FDA 483 Nana Barseghian, M.D., Northridge | 2024
Out-of-stock
Jasmine Y. Wang
Human Drugs Form 483
FDA 483 Jay Patel, M.D., Pasadena | 2024
Out-of-stock
Jasmine Y. Wang
Human Drugs Form 483
Co-Investigators (13)
- Joanne M. Schlossin, FDA Investigator
- Habacuc V. Barrera, FDA Investigator
- Raman K. Kaushal,
- Samson O. Oluseye, FDA Investigator
- Cheron M. Portee, FDA Investigator
- Farwa Z. Razvi, FDA Investigator
- Korina Serrano,
- Grace P. Santos, FDA Investigator
- Colleen E. Burke, FDA Investigator
- Julian C. Hanson, FDA Investigator
- Jeanne J. Thai, FDA Investigator
- Lan T. Tran, FDA Investigator
- Corrine M. Carter, FDA Investigator